threonine has been researched along with Kaposi Sarcoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biberfeld, P; Järviluoma, A; Laiho, M; Moore, HM; Ojala, PM; Sarek, G; Tojkander, S; Vartia, S | 1 |
Järviluoma, A; Ojala, PM; Sarek, G | 1 |
Hayward, SD; Liao, G; Liu, J; Martin, HJ | 1 |
Bonavida, B; Mori, S; Murakami-Mori, K; Nakamura, S | 1 |
4 other study(ies) available for threonine and Kaposi Sarcoma
Article | Year |
---|---|
Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Topics: Acetylation; Antigens, Viral; Cell Line, Tumor; Cyclin-Dependent Kinase 6; Herpesvirus 8, Human; Humans; Nuclear Proteins; Nucleophosmin; Phosphorylation; RNA, Small Interfering; Sarcoma, Kaposi; Threonine; Virus Latency; Virus Replication | 2010 |
KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas.
Topics: Cell Proliferation; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cytoplasm; Fluorescent Antibody Technique, Indirect; Herpesvirus 8, Human; Humans; Immunoblotting; Immunoprecipitation; Lymphoma, AIDS-Related; Phosphorylation; Protein Transport; Sarcoma, Kaposi; Serine; Subcellular Fractions; Threonine; Tumor Cells, Cultured; Viral Proteins; Virus Replication | 2006 |
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
Topics: Amino Acid Sequence; Antigens, Viral; Cell Line, Tumor; Glycogen Synthase Kinase 3; Herpesvirus 8, Human; Humans; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; Nuclear Proteins; Phosphorylation; Proto-Oncogene Proteins c-myc; Sarcoma, Kaposi; Serine; Threonine; Ubiquitin | 2007 |
Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in K
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Antigens, CD; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Cell Division; Dactinomycin; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Growth Substances; Guanine Nucleotide Exchange Factors; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Sarcoma, Kaposi; Threonine; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tyrosine | 1999 |